Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine

Ruth Alexandra Ross, H C Brockie, S R Fernando, B Saha, R K Razdan, Roger Guy Pertwee

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

1 We have investigated the nature of cannabinoid receptors in guinea-pig small intestine by establishing whether this tissue contains cannabinoid receptors with similar binding properties to those of brain CBI receptors. The cannabinoids used were the CB1-selective antagonist SR141716A, the CB,-selective antagonist SR144528, the novel cannabinoid receptor ligand, 6'-azidohex-2'-yne-Delta 8-tetrahydrocannabinol (O-1184), and the agonists CP55940, which binds equally well to CBI and CB2 receptors, and WIN55212-2, which shows marginal CB2 selectivity.

2 [[H-3]-CP55940 (1 nM) underwent extensive specific binding both to forebrain membranes (76.3%) and to membranes obtained by sucrose density gradient fractionation of homogenates of myenteric plexuslongitudinal muscle of guinea-pig small intestine (65.2%).

3 Its binding capacity (B-max) was higher in forebrain (4281 fmol mg(-1)) than in intestinal membranes (2092 fmol mg(-1)). However, the corresponding K-D values were not significantly different from each other (2.29 and 1.75 nM respectively). Nor did the K-i values for its displacement by CP55940, WIN55212-2, O-1184, SR141716A and SR144528 from forebrain membranes (0.87, 4.15, 2.85, 5.32 and 371.9 respectively) differ significantly from the corresponding Ki values determined in experiments with intestinal membranes (0.99, 5.03, 3.16, 4.95 and 361.5 nM respectively).

4 The B-max values of [H-3]-CP55940 and [H-3]-SR141716A in forebrain membranes did not differ significantly from each other (4281 and 5658 fmol mg-1) but were both greater than the B-max of [H-3](-) WIN55212-2 (2032 fmol mg(-1)).

5 O-1184 (10 or 100 nM) produced parallel dextral shifts in the log concentration-response curves of WIN55212-2 and CP55940 for inhibition of electrically-evoked contractions of the myenteric plexuslongitudinal muscle preparation, its K-D values being 0.20 nM (against WIN55212-2) and 0.89 nM (against CP55940).

6 We conclude that cannabinoid binding sites in guinea-pig small intestine closely resemble CB1 binding sites of guinea-pig brain and that 0-1184 behaves as a cannabinoid receptor antagonist in the guinea-pig myenteric plexus-longitudinal muscle preparation.

Original languageEnglish
Pages (from-to)1345-1351
Number of pages7
JournalBritish Journal of Pharmacology
Volume125
Issue number6
DOIs
Publication statusPublished - Nov 1998

Keywords

  • cannabinoid receptors
  • myenteric plexus
  • guinea-pig small intestine
  • guinea-pig brain
  • 6 '-azidohex-2 '-yne-Delta(8)-tetrahydrocannabinol
  • O-1184
  • cannabinoid receptor antagonists
  • RECEPTOR
  • AGONISTS
  • Cannabinoid receptors
  • myenteric plexus
  • guinea-pig small intestine
  • 6'-azidohex-2'-yne-¿8-tetrahydrocannabinol
  • O-1184

Cite this

Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine. / Ross, Ruth Alexandra; Brockie, H C ; Fernando, S R ; Saha, B ; Razdan, R K ; Pertwee, Roger Guy.

In: British Journal of Pharmacology, Vol. 125, No. 6, 11.1998, p. 1345-1351.

Research output: Contribution to journalArticle

Ross, Ruth Alexandra ; Brockie, H C ; Fernando, S R ; Saha, B ; Razdan, R K ; Pertwee, Roger Guy. / Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine. In: British Journal of Pharmacology. 1998 ; Vol. 125, No. 6. pp. 1345-1351.
@article{1fb27f76ee2444749480fb75293c15e8,
title = "Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine",
abstract = "1 We have investigated the nature of cannabinoid receptors in guinea-pig small intestine by establishing whether this tissue contains cannabinoid receptors with similar binding properties to those of brain CBI receptors. The cannabinoids used were the CB1-selective antagonist SR141716A, the CB,-selective antagonist SR144528, the novel cannabinoid receptor ligand, 6'-azidohex-2'-yne-Delta 8-tetrahydrocannabinol (O-1184), and the agonists CP55940, which binds equally well to CBI and CB2 receptors, and WIN55212-2, which shows marginal CB2 selectivity.2 [[H-3]-CP55940 (1 nM) underwent extensive specific binding both to forebrain membranes (76.3{\%}) and to membranes obtained by sucrose density gradient fractionation of homogenates of myenteric plexuslongitudinal muscle of guinea-pig small intestine (65.2{\%}).3 Its binding capacity (B-max) was higher in forebrain (4281 fmol mg(-1)) than in intestinal membranes (2092 fmol mg(-1)). However, the corresponding K-D values were not significantly different from each other (2.29 and 1.75 nM respectively). Nor did the K-i values for its displacement by CP55940, WIN55212-2, O-1184, SR141716A and SR144528 from forebrain membranes (0.87, 4.15, 2.85, 5.32 and 371.9 respectively) differ significantly from the corresponding Ki values determined in experiments with intestinal membranes (0.99, 5.03, 3.16, 4.95 and 361.5 nM respectively).4 The B-max values of [H-3]-CP55940 and [H-3]-SR141716A in forebrain membranes did not differ significantly from each other (4281 and 5658 fmol mg-1) but were both greater than the B-max of [H-3](-) WIN55212-2 (2032 fmol mg(-1)).5 O-1184 (10 or 100 nM) produced parallel dextral shifts in the log concentration-response curves of WIN55212-2 and CP55940 for inhibition of electrically-evoked contractions of the myenteric plexuslongitudinal muscle preparation, its K-D values being 0.20 nM (against WIN55212-2) and 0.89 nM (against CP55940).6 We conclude that cannabinoid binding sites in guinea-pig small intestine closely resemble CB1 binding sites of guinea-pig brain and that 0-1184 behaves as a cannabinoid receptor antagonist in the guinea-pig myenteric plexus-longitudinal muscle preparation.",
keywords = "cannabinoid receptors, myenteric plexus, guinea-pig small intestine, guinea-pig brain, 6 '-azidohex-2 '-yne-Delta(8)-tetrahydrocannabinol, O-1184, cannabinoid receptor antagonists, RECEPTOR, AGONISTS, Cannabinoid receptors , myenteric plexus , guinea-pig small intestine , 6'-azidohex-2'-yne-¿8-tetrahydrocannabinol , O-1184",
author = "Ross, {Ruth Alexandra} and Brockie, {H C} and Fernando, {S R} and B Saha and Razdan, {R K} and Pertwee, {Roger Guy}",
year = "1998",
month = "11",
doi = "10.1038/sj.bjp.0702204",
language = "English",
volume = "125",
pages = "1345--1351",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine

AU - Ross, Ruth Alexandra

AU - Brockie, H C

AU - Fernando, S R

AU - Saha, B

AU - Razdan, R K

AU - Pertwee, Roger Guy

PY - 1998/11

Y1 - 1998/11

N2 - 1 We have investigated the nature of cannabinoid receptors in guinea-pig small intestine by establishing whether this tissue contains cannabinoid receptors with similar binding properties to those of brain CBI receptors. The cannabinoids used were the CB1-selective antagonist SR141716A, the CB,-selective antagonist SR144528, the novel cannabinoid receptor ligand, 6'-azidohex-2'-yne-Delta 8-tetrahydrocannabinol (O-1184), and the agonists CP55940, which binds equally well to CBI and CB2 receptors, and WIN55212-2, which shows marginal CB2 selectivity.2 [[H-3]-CP55940 (1 nM) underwent extensive specific binding both to forebrain membranes (76.3%) and to membranes obtained by sucrose density gradient fractionation of homogenates of myenteric plexuslongitudinal muscle of guinea-pig small intestine (65.2%).3 Its binding capacity (B-max) was higher in forebrain (4281 fmol mg(-1)) than in intestinal membranes (2092 fmol mg(-1)). However, the corresponding K-D values were not significantly different from each other (2.29 and 1.75 nM respectively). Nor did the K-i values for its displacement by CP55940, WIN55212-2, O-1184, SR141716A and SR144528 from forebrain membranes (0.87, 4.15, 2.85, 5.32 and 371.9 respectively) differ significantly from the corresponding Ki values determined in experiments with intestinal membranes (0.99, 5.03, 3.16, 4.95 and 361.5 nM respectively).4 The B-max values of [H-3]-CP55940 and [H-3]-SR141716A in forebrain membranes did not differ significantly from each other (4281 and 5658 fmol mg-1) but were both greater than the B-max of [H-3](-) WIN55212-2 (2032 fmol mg(-1)).5 O-1184 (10 or 100 nM) produced parallel dextral shifts in the log concentration-response curves of WIN55212-2 and CP55940 for inhibition of electrically-evoked contractions of the myenteric plexuslongitudinal muscle preparation, its K-D values being 0.20 nM (against WIN55212-2) and 0.89 nM (against CP55940).6 We conclude that cannabinoid binding sites in guinea-pig small intestine closely resemble CB1 binding sites of guinea-pig brain and that 0-1184 behaves as a cannabinoid receptor antagonist in the guinea-pig myenteric plexus-longitudinal muscle preparation.

AB - 1 We have investigated the nature of cannabinoid receptors in guinea-pig small intestine by establishing whether this tissue contains cannabinoid receptors with similar binding properties to those of brain CBI receptors. The cannabinoids used were the CB1-selective antagonist SR141716A, the CB,-selective antagonist SR144528, the novel cannabinoid receptor ligand, 6'-azidohex-2'-yne-Delta 8-tetrahydrocannabinol (O-1184), and the agonists CP55940, which binds equally well to CBI and CB2 receptors, and WIN55212-2, which shows marginal CB2 selectivity.2 [[H-3]-CP55940 (1 nM) underwent extensive specific binding both to forebrain membranes (76.3%) and to membranes obtained by sucrose density gradient fractionation of homogenates of myenteric plexuslongitudinal muscle of guinea-pig small intestine (65.2%).3 Its binding capacity (B-max) was higher in forebrain (4281 fmol mg(-1)) than in intestinal membranes (2092 fmol mg(-1)). However, the corresponding K-D values were not significantly different from each other (2.29 and 1.75 nM respectively). Nor did the K-i values for its displacement by CP55940, WIN55212-2, O-1184, SR141716A and SR144528 from forebrain membranes (0.87, 4.15, 2.85, 5.32 and 371.9 respectively) differ significantly from the corresponding Ki values determined in experiments with intestinal membranes (0.99, 5.03, 3.16, 4.95 and 361.5 nM respectively).4 The B-max values of [H-3]-CP55940 and [H-3]-SR141716A in forebrain membranes did not differ significantly from each other (4281 and 5658 fmol mg-1) but were both greater than the B-max of [H-3](-) WIN55212-2 (2032 fmol mg(-1)).5 O-1184 (10 or 100 nM) produced parallel dextral shifts in the log concentration-response curves of WIN55212-2 and CP55940 for inhibition of electrically-evoked contractions of the myenteric plexuslongitudinal muscle preparation, its K-D values being 0.20 nM (against WIN55212-2) and 0.89 nM (against CP55940).6 We conclude that cannabinoid binding sites in guinea-pig small intestine closely resemble CB1 binding sites of guinea-pig brain and that 0-1184 behaves as a cannabinoid receptor antagonist in the guinea-pig myenteric plexus-longitudinal muscle preparation.

KW - cannabinoid receptors

KW - myenteric plexus

KW - guinea-pig small intestine

KW - guinea-pig brain

KW - 6 '-azidohex-2 '-yne-Delta(8)-tetrahydrocannabinol

KW - O-1184

KW - cannabinoid receptor antagonists

KW - RECEPTOR

KW - AGONISTS

KW - Cannabinoid receptors

KW - myenteric plexus

KW - guinea-pig small intestine

KW - 6'-azidohex-2'-yne-¿8-tetrahydrocannabinol

KW - O-1184

U2 - 10.1038/sj.bjp.0702204

DO - 10.1038/sj.bjp.0702204

M3 - Article

VL - 125

SP - 1345

EP - 1351

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 6

ER -